Raw material of veterinary medicine Doxycycline Hyclate Powder

CAS:24390-14-5

MF:C24H31ClN2O9

MW:526.97

EINECS:2017-001-1

Specification: 99% min Doxycycline Hyclate Powder

Sample:Doxycycline Hyclate Powder

Packaging:1kg/bag, 25kg/drum

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Doxycycline Hyclate Powder Usage and Synthesis.

Doxycycline hydrochloride is a semi-synthetic tetracycline antibiotic that penetrates cell membranes and binds to the 30S ribosomal subunit, interfering with tRNA/mRNA interactions and ultimately inhibiting protein synthesis.

As a broad-spectrum antibiotic and bacteriostatic agent, this antibiotic is very resistant primarily to bacteria that cause respiratory tract infections including Mycoplasma pneumoniae and Haemophilus influenzae.

It also treats infections caused by Chlamydia, Rickettsia, and certain spirochetes and has antiprotozoal and deworming properties.

Uses and functions of Doxycycline Hyclate.

Doxycycline Hydrochloride is commonly used for the treatment of small animal infections caused by a number of different microorganisms, including Borrelia, Leptospira, Rickettsia, Chlamydia, Mycoplasma, Bartonella and Bordetella.

Pharmacological Effect of Doxycycline Hyclate.

Tetracycline antibiotics are bacteriostatic antibiotics that inhibit protein synthesis by reversibly binding to the 30S ribosomal subunit of sensitive bacteria and thereby preventing their binding to aminoacyl transfer RNA.Chemicalbook.It has also been suggested that tetracyclines can reversibly bind to the 50S subunit and alter the permeability of sensitive bacterial cell membranes, and can also inhibit protein synthesis in mammalian cells at high concentrations.

In vivo studies of  Bulk Doxycycline Hyclate Powder.

Doxycyclinehyclate is an effective treatment for acute E. canis infections in puppies.

Doxycyclinehyclate (5 mg/kg, orally) decreased collagenase activity in rabbit cornea. Doxycyclinehyclate (5 mg/kg, orally) promoted corneal epidermal cell regeneration in a rabbit alkali burn model, a result that may be attributed to the drug's inhibition of excess collagenase activity.

Doxycyclinehyclate would have prevented 43% of the mice treated orally, in contrast to the extended-release doxycyclinehyclate, which completely protects mice from infections and pathologies caused by infections.

Doxycyclinehyclate has a bioavailability of 70%, a Cmin of 1 mg/L, a Cmax of 2.3 mg/L and a half-life of 7 hours in calves with immature rumen function.